Morgan Stanley initiated coverage on shares of DexCom (NASDAQ:DXCM – Get Rating) in a research report released on Tuesday, FinViz reports. The firm issued an equal weight rating and a $131.00 target price on the medical device company’s stock. Other equities research analysts have also issued reports about the stock. TheStreet lowered shares of DexCom […]